This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


trusted source


Research team identifies new approach to tackling bacterial infections

New approach to tackling bacterial infections identified
Icahn Mount Sinai researchers unveil how the self-killing activity of bacteria can be used in the fight against antibiotic resistance. Above: 3D structure of CBASS Cap5 protein tetramer (shown in cyan) formed upon binding to the cyclic dinucleotide (shown in orange) to destroy bacteria's own DNA (model, shown in red). Essential magnesium ions for DNA cleavage are shown in green. Credit: Nature Structural & Molecular Biology (2024). DOI: 10.1038/s41594-024-01220-x

Researchers at the Icahn School of Medicine at Mount Sinai have identified a new approach to controlling bacterial infections. The findings are described in Nature Structural & Molecular Biology.

The team found a way to turn on a vital bacterial defense mechanism to fight and manage bacterial infections. The , called cyclic oligonucleotide-based antiphage signaling system (CBASS), is a natural mechanism used by certain bacteria to protect themselves from viral attacks. Bacteria self-destruct as a means to prevent the spread of virus to other in the population.

"We wanted to see how the bacterial self-killing CBASS system is activated and whether it can be leveraged to limit bacterial infections," says co-senior author Aneel Aggarwal, Ph.D., Professor of Pharmacological Sciences at Icahn Mount Sinai. "This is a fresh approach to tackling bacterial infections, a significant concern in hospitals and other settings. It's essential to find new tools for fighting antibiotic resistance. In the war against superbugs, we need to constantly innovate and expand our toolkit to stay ahead of evolving drug resistance."

According to a 2019 report by the Centers for Disease Control and Prevention, more than 2.8 million antimicrobial-resistant infections occur in the United States each year, with over 35,000 people dying as a result.

As part of the experiments, the researchers studied how Cap5, or CBASS-associated protein 5, is activated for DNA degradation and how it could be used to control bacterial infections through a combination of structural analysis and various biophysical, biochemical, and cellular assays. Cap5 is a key protein that becomes activated by cyclic nucleotides (small signaling molecules) to destroy the bacterial cell's own DNA.

"In our study, we started by identifying which of the many cyclic nucleotides could activate the effector Cap5 of the CBASS system," says co-senior author Olga Rechkoblit, Ph.D., Assistant Professor of Pharmacological Sciences at Icahn Mount Sinai.

"Once we figured that out, we looked closely at the structure of Cap5 when it's bound to these small signaling molecules. Then, with expert help from Daniela Sciaky, Ph.D., a researcher at Icahn Mount Sinai, we showed that by adding these special molecules to the bacteria's environment, these molecules could potentially be used to eliminate the bacteria."

The researchers found that determining the structure of Cap5 with cyclic nucleotides posed a , requiring expert help from Dale F. Kreitler, Ph.D., AMX Beamline Scientist at Brookhaven National Laboratory. They achieved it by using micro-focused synchrotron X-ray radiation at the same facility. Micro-focused synchrotron X-ray radiation is a type of X-ray radiation that is not only produced using a specific type of particle accelerator (synchrotron), but is also carefully concentrated or focused on a tiny area for more detailed imaging or analysis.

Next, the researchers will explore how their discoveries apply to other types of bacteria and assess whether their method can be used to manage infections caused by various harmful bacteria.

Other authors who contributed to this work are Angeliki Buku, Ph.D., and Jithesh Kottur, Ph.D., both with Icahn Mount Sinai.

More information: Olga Rechkoblit et al, Activation of CBASS Cap5 endonuclease immune effector by cyclic nucleotides, Nature Structural & Molecular Biology (2024). DOI: 10.1038/s41594-024-01220-x

Citation: Research team identifies new approach to tackling bacterial infections (2024, February 6) retrieved 19 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Bacterial immune system boosts antibiotic effectiveness against cholera, study reveals


Feedback to editors